Platford Giles Richard sold 55,617 shares of TAKEDA PHARMACEUTICAL CO LTD on Nov 4, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
President, IBU
President, IBU
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
55,617American Depositary Shares
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
17.07%This security and ownership context
Holdings after
270,253Direct
Trade date
Nov 4, 2026Sell
Filed
Nov 5, 2026, 3:54 PM ET1-day reporting delay
Accession
0001395064-26-000349Code S · Transaction 393336
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 325,870 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

TAK price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TAK · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −16%1w ago −8.2%1d ago −8.2%
Returns since7d −1.7%30d90d180d1y

Footnotes in full

F1: Includes 10,032 ADS received upon the vesting of dividend equivalent units that were not included in the reporting person's previously filed Form 4.